Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lanying Du

Showing results (1-10 of 182) with videos related to

Pageof 19
Sort By:
Trends in Immunology|September 1, 2020
Effect of Low-Pathogenic Human Coronavirus-Specific Antibodies on SARS-CoV-2Shibo Jiang, Lanying Du
Cellular & Molecular Immunology|May 27, 2018
Advances in the research and development of therapeutic antibodies against the Zika virusShibo Jiang, Lanying Du
Future Virology|March 24, 2020
Immunotherapy of SARS based on combinations of neutralizing human monoclonal antibodiesLanying Du, Shibo Jiang
Cellular & Molecular Immunology|June 24, 2022
Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variantsYang Yang, Lanying Du
Viruses|July 24, 2019
MERS Coronavirus: An Emerging Zoonotic VirusFang Li, Lanying Du
Expert Opinion on Biological Therapy|September 29, 2015
Middle East respiratory syndrome: current status and future prospects for vaccine developmentLanying Du, Shibo Jiang
Signal Transduction and Targeted Therapy|February 27, 2021
SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodiesYang Yang, Lanying Du
Trends in Immunology|May 5, 2020
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355-359; 2020)Shibo Jiang, Christopher Hillyer, Lanying Du
Expert Review of Vaccines|April 29, 2014
Current advancements and potential strategies in the development of MERS-CoV vaccinesNaru Zhang, Shibo Jiang, Lanying Du
Journal of Nanobiotechnology|May 31, 2024
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronavirusesYang Yang, Fang Li, Lanying Du
Pageof 19

Showing results (1-10 of 182) with videos related to

Sort By:
Pageof 19
Trends in Immunology|September 1, 2020
Effect of Low-Pathogenic Human Coronavirus-Specific Antibodies on SARS-CoV-2Shibo Jiang, Lanying Du
Cellular & Molecular Immunology|May 27, 2018
Advances in the research and development of therapeutic antibodies against the Zika virusShibo Jiang, Lanying Du
Future Virology|March 24, 2020
Immunotherapy of SARS based on combinations of neutralizing human monoclonal antibodiesLanying Du, Shibo Jiang
Cellular & Molecular Immunology|June 24, 2022
Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variantsYang Yang, Lanying Du
Viruses|July 24, 2019
MERS Coronavirus: An Emerging Zoonotic VirusFang Li, Lanying Du
Expert Opinion on Biological Therapy|September 29, 2015
Middle East respiratory syndrome: current status and future prospects for vaccine developmentLanying Du, Shibo Jiang
Signal Transduction and Targeted Therapy|February 27, 2021
SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodiesYang Yang, Lanying Du
Trends in Immunology|May 5, 2020
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355-359; 2020)Shibo Jiang, Christopher Hillyer, Lanying Du
Expert Review of Vaccines|April 29, 2014
Current advancements and potential strategies in the development of MERS-CoV vaccinesNaru Zhang, Shibo Jiang, Lanying Du
Journal of Nanobiotechnology|May 31, 2024
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronavirusesYang Yang, Fang Li, Lanying Du
Pageof 19